Sulodexide, traded as Aterina, is a highly purified mixture of glycosaminoglycans composed of heparan sulfate (80%) and dermatan sulfate (20%).
Pharmacology
The low molecular weight of both sulodexide fractions allows for extensive oral absorption compared to unfractionated
heparin. The pharmacological effects of sulodexide differ substantially from other glycosaminoglycans and are mainly characterized by a prolonged half-life and reduced effect on global coagulation and bleeding parameters.
Due to the presence of both glycosaminoglycan fractions, sulodexide potentiates the antiprotease activities of both
antithrombin III and heparin cofactor II simultaneously.
Uses
Clinically, sulodexide is used for the prophylaxis and treatment of thromboembolic diseases. Research has also demonstrated the beneficial effects of sulodexide in animal models of reperfusion injury
and the treatment of diabetic nephropathy.
In combination with
melatonin, sulodexide has been shown to be a viable treatment option for patients suffering from central or sensorineural
tinnitus.
There have also been positive results in treating tinnitus using sulodexide as a monotherapy.
Sulodexide has also been effectively used in the treatment of chronic venous disease.
External links
